Received for publication October 24, 2007.
Revised January 28, 2008.
Accepted for publication January 28, 2008.

Glucuronidation of tobacco-specific nitrosamines by UGT2B10

Abstract

NNAL (4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol) is an important tobacco-specific nitrosamine (TSNA) in the etiology of tobacco-related cancers and N-glucuronidation is an important mechanism of NNAL detoxification. In the present study, an analysis of the UDP-glucuronosyltranferases (UGTs) responsible for the N-glucuronidation of the TSNAs N'-nitrosonornicotine, N'-nitrosoanabasine and N'-nitrosoanatabine was performed. Utilizing HEK293 cells over-expressing UGTs 1A1, 1A3, 1A4, 1A6, 1A7, 1A8, 1A9, 1A10, 2B4, 2B7, 2B10, 2B11, 2B15, and 2B17, only UGTs 1A4 and 2B10 exhibited N-glucuronidating activity against these TSNAs. The K_M's for UGT2B10 were 15-22-fold lower than those of UGT1A4 against the three TSNAs, and were similar to those observed for microsomes prepared from human liver specimens. The overall activity of UGT2B10 was 3.6-27-fold higher than UGT1A4 against the three TSNAs as determined by V_max/K_M after normalization by levels of UGT2B10 versus UGT1A4 mRNA. Similarly high levels of activity were also observed for UGT2B10 against a fourth TSNA, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), exhibiting a 6.3-fold lower K_M and 3-fold higher normalized V_max/K_M than that observed for UGT1A4. Real-time PCR analysis demonstrated that UGT2B10 was expressed at a level that, on average, was 26% higher than that observed for UGT1A4 in a screening of normal liver tissue specimens from 20 individual subjects. These data suggest that UGT2B10 is likely the most active UGT isoform in human liver for the N-glucuronidation of TSNAs.

Key words: carcinogen metabolism, glucuronidation, hepatic elimination, HPLC, lung cancer, UDP glucuronyltransferases

This article has been cited by other articles:

				O. Kerdpin, P. I. Mackenzie, K. Bowalgaha, M. Finel, and J. O. Miners Influence of N-Terminal Domain Histidine and Proline Residues on the Substrate Selectivities of Human UDP-Glucuronosyltransferase 1A1, 1A6, 1A9, 2B7, and 2B10 Drug Metab. Dispos., September 1, 2009; 37(9): 1948 - 1955. [Abstract] [Full Text] [PDF]

				R. M. Balliet, G. Chen, C. J. Gallagher, R. W. Dellinger, D. Sun, and P. Lazarus Characterization of UGTs Active against SAHA and Association between SAHA Glucuronidation Activity Phenotype with UGT Genotype Cancer Res., April 1, 2009; 69(7): 2981 - 2989. [Abstract] [Full Text] [PDF]

				J. E. Muscat, G. Chen, A. Knipe, S. D. Stellman, P. Lazarus, and J. P. Richie Jr. Effects of Menthol on Tobacco Smoke Exposure, Nicotine Dependence, and NNAL Glucuronidation Cancer Epidemiol. Biomarkers Prev., January 1, 2009; 18(1): 35 - 41. [Abstract] [Full Text] [PDF]